Universe Pharmaceuticals INC Retained Earnings
Universe Pharmaceuticals INC (UPC) had Retained Earnings of -$13.84 billion as of 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-01-29
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$13.84B.
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$10.17B; Retained Earnings (Accumulated Deficit) as first filed -$10.17M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$2.94M.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$1.44M; Retained Earnings (Accumulated Deficit) as first filed $10.16M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2025-09-30 | -$13.84B 20-F · filed 2026-01-29 | |
| 2024-09-30 | -$10.17B 20-F · filed 2026-01-29 | -$10.17M 20-F · filed 2025-04-29 |
| 2024-03-31 | -$2.94M 6-K · filed 2024-09-20 | |
| 2023-09-30 | -$1.44M 20-F · filed 2025-04-29 | $10.16M 20-F · filed 2024-01-30 |
| 2023-03-31 | $15.61M 6-K · filed 2023-08-31 | |
| 2022-09-30 | $16.32M 20-F · filed 2024-01-30 | |
| 2022-03-31 | $26.79M 6-K · filed 2022-08-16 | |
| 2021-09-30 | $25.06M 20-F · filed 2023-02-10 | |
| 2020-09-30 | $13.74M 20-F · filed 2022-01-31 |